北京美科美生物公司代理Allele biotech

NANOANTIBODIES
CELL THERAPY
COVID-19

Allele Biotechnology and Pharmaceuticals，Inc。是一家位于圣地亚哥的私营公司，致力于研究生物过程的机制，以开发用于生物医学研究和治疗开发的技术和产品。
我们的使命是通过在个别产品和完全集成的平台中提供技术，提高创新分子生物学研究工具的可及性。
Allele利用专有的非整合细胞重编程方法实现药物发现和细胞治疗，包括人类和非人灵长类动物iPS细胞，GMP级人类iPS细胞及其衍生物，以及分化细胞类型。凭借在基因组修饰和基于细胞的传感器/报告器方面的额外专业知识，Allele提供先进的细胞和分析开发解决方案
Allele还开发了多种试剂，包括优质荧光蛋白，高效荧光素酶测定底物，基因分型试剂盒和骆驼抗体。该公司还在RNAi领域处于地位，其包括Pol III启动子驱动的siRNA，shRNA和miRNA
Established in 1999 Allele Biotechnology has focused on developing and adapting cutting edge technology for clinical and therapeutic use. Over the years Allele’s  has worked on biological advancements that have been at the forefront of molecular biology research, including RNA interference, Fluorescent Proteins, Induced Pluripotent Stem Cells (iPSCs),  Genome Editing, and camelid derived Single Domain Antibodies. In 2015 Allele established a cGMP facility in San Diego to further the clinical development of  iPSC based cell therapy.